Biomarker Assessment of Venous Thromboembolism in Cancer Patients Receiving Checkpoint Blockade

被引：3
|
作者：
Swaidani, Shadi [1 ,2 ]
Roopkumar, Joanna [3 ]
Jun-Shim, Young [1 ]
Charles, Cathy [1 ]
Paul, Slato [1 ]
Kundu, Suman [1 ]
Funchain, Pauline [3 ]
Rayman, Patricia [2 ]
Pavicic, Paul G. [2 ]
Diaz-Montero, C. Marcela [2 ]
Khorana, Alok A. [3 ]
McCrae, Keith R. [1 ,3 ]
机构：
[1] Cleveland Clin, Cardiovasc & Metab Sci, Cleveland, OH 44106 USA
[2] Cleveland Clin, Inflammat and Immun, Cleveland, OH 44106 USA
[3] Cleveland Clin, Dept Hematol & Med Oncol, Taussig Canc Inst, Cleveland, OH 44106 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-130911
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3648
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Validation of risk assessment scores in predicting venous thromboembolism in patients with lung cancer receiving immune checkpoint inhibitors
    Zhang, Jiarui
    Xie, Yufang
    Yang, Linhui
    Yang, Mengzhu
    Xu, Rui
    Liu, Dan
    BMC PULMONARY MEDICINE, 2024, 24 (01):
  • [2] Venous Thromboembolism in Cancer Patients Receiving Immunotherapy
    Roopkumar, Joanna
    Kim, Ann S.
    Bicky, Thapa
    Hobbs, Brian P.
    Khorana, Alok A.
    BLOOD, 2018, 132
  • [3] Venous thromboembolism in patients receiving chemotherapy for breast cancer
    Plant, R. E.
    Walter, H. S.
    Ahmed, S. I.
    CANCER RESEARCH, 2013, 73
  • [4] Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors
    Icht, Oded
    Darzi, Naama
    Shimony, Shai
    Jacobi, Oded
    Reinhorn, Daniel
    Landman, Yosef
    Mutai, Raz
    Averbuch, Itamar
    Shochat, Tzippy
    Spectre, Galia
    Raanani, Pia
    Rotem, Ofer
    Dudnik, Elizabeth
    Peled, Nir
    Zer, Alona
    Leader, Avi
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (05) : 1250 - 1258
  • [5] Outcomes in Patients with Cancer-Associated Venous Thromboembolism Receiving Immune Checkpoint Inhibitors: A Matched Cohort Study
    Danielian, Pedro Luiz Lage Bodour
    Dave, Heloni M.
    Wei, Wei
    Patel, Mehrie H.
    Angelini, Dana Elizabeth
    Khorana, Alok A.
    BLOOD, 2024, 144 : 5578 - 5579
  • [6] Venous thromboembolism risk in cancer patients receiving first-line immune checkpoint inhibitor versus chemotherapy
    Li, Ang
    May, Sarah B.
    La, Jennifer
    Martens, Kylee L.
    Amos, Christopher I.
    Flowers, Christopher R.
    Do, Nhan V.
    Brophy, Mary T.
    Chitalia, Vipul
    Ravid, Katya
    Gaziano, John Michael
    Fillmore, Nathanael R.
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (08) : 1214 - 1222
  • [7] Venous Thromboembolism in Patients with Cancer Receiving Specialist Palliative Care
    Rosa Allende-Perez, Silvia
    Cesarman-Maus, Gabriela
    Pena-Nieves, Adriana
    Arcos, Amelia
    Baz-Gutierrez, Patricia
    Robles, Joanna
    LeBlanc, Thomas W.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [8] Semuloparin reduced venous thromboembolism in patients receiving chemotherapy for cancer
    Hull, Russell D.
    ANNALS OF INTERNAL MEDICINE, 2012, 156 (12)
  • [9] Venous Thromboembolism in Patients with Cancer Receiving Specialist Palliative Care
    Allende-Perez, Silvia Rosa
    Cesarman-Maus, Gabriela
    Pena-Nieves, Adriana
    Arcos, Amelia
    Baz-Gutierrez, Patricia
    Robles, Joanna
    LeBlanc, Thomas W.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [10] Prediction of venous thromboembolism in lung cancer patients receiving chemotherapy
    Noble, S.
    Robbins, A.
    Alikhan, R.
    Hood, K.
    Macbeth, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 143 - 143
12345